Trader Brian Jones@MasterBJones$MORF was the only stock that went much higher. After this one no stock went up over 40%.7:19 PM · Mar 1, 2021·Twitter Web App2 Retweets7 Likes
Numenor@numenorcap·Oct 13, 2021AutomatedReplying to @MasterBJones and @traderbjonesseekingalpha.comMorphic Therapeutic Stock: Pioneering Integrin Medicines (NASDAQ:MORF)Morphic is pursuing a multi-billion opportunity of replacing biologics modulating integrins with small molecules. See why I’m neutral on MORF stock here.
